{"id":"https://openalex.org/W3085873532","doi":"https://doi.org/10.1016/j.vhri.2020.07.154","title":"PCN104 Treatment Patterns and Health Resource Utilization in Patients with HR+/HER2- Locally Advanced or Metastatic Breast Cancer in Real World Setting in Taiwan","display_name":"PCN104 Treatment Patterns and Health Resource Utilization in Patients with HR+/HER2- Locally Advanced or Metastatic Breast Cancer in Real World Setting in Taiwan","publication_year":2020,"publication_date":"2020-09-01","ids":{"openalex":"https://openalex.org/W3085873532","doi":"https://doi.org/10.1016/j.vhri.2020.07.154","mag":"3085873532"},"language":"en","primary_location":{"id":"doi:10.1016/j.vhri.2020.07.154","doi":"https://doi.org/10.1016/j.vhri.2020.07.154","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2020.07.154","pdf_url":null,"source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","medline","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1016/j.vhri.2020.07.154","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"N. Rajan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114640","display_name":"Eli Lilly (India)","ror":"https://ror.org/02156y972","country_code":"IN","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210114640"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"N. Rajan","raw_affiliation_strings":["Eli Lilly Services India Private Limited, Devarabeesanahalli, Varthur Hobli, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Services India Private Limited, Devarabeesanahalli, Varthur Hobli, India","institution_ids":["https://openalex.org/I4210114640"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Wei","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Wei","raw_affiliation_strings":["Eli Lilly and Company (Taiwan), Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company (Taiwan), Taipei, Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Cheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Cheng","raw_affiliation_strings":["Eli Lilly and Company (Taiwan), Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company (Taiwan), Taipei, Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107876782","display_name":"Diego Novick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095227","display_name":"Eli Lilly (United Kingdom)","ror":"https://ror.org/00psab413","country_code":"GB","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210095227"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Novick","raw_affiliation_strings":["Eli Lilly and Company, Windlesham, SRY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Windlesham, SRY, UK","institution_ids":["https://openalex.org/I4210095227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004380370","display_name":"Sam Colman","orcid":"https://orcid.org/0000-0002-7749-6345","observed_orcids":["https://orcid.org/0000-0002-7749-6345"]},"institutions":[{"id":"https://openalex.org/I4210149209","display_name":"Covance (Australia)","ror":"https://ror.org/048b5ng26","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210149209","https://openalex.org/I60638368"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"S. Colman","raw_affiliation_strings":["Covance, Macquarie Park, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance, Macquarie Park, NSW, Australia","institution_ids":["https://openalex.org/I4210149209"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002095623","display_name":"\u00c1gota Szende","orcid":"https://orcid.org/0000-0002-5880-3354","observed_orcids":["https://orcid.org/0000-0002-5880-3354"]},"institutions":[{"id":"https://openalex.org/I4210166171","display_name":"Covance (United Kingdom)","ror":"https://ror.org/059vag305","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210166171","https://openalex.org/I60638368"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Szende","raw_affiliation_strings":["Covance, Leeds, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance, Leeds, UK","institution_ids":["https://openalex.org/I4210166171"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1500,"currency":"USD","value_usd":1500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":null,"first_page":"S24","last_page":"S25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.5264000296592712,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.5264000296592712,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.27320000529289246,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.07530000060796738,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.8379999995231628},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.9520000219345093},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":1.0},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9459999799728394},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.9300000071525574},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.8149999976158142},{"id":"https://openalex.org/keywords/postmenopausal-women","display_name":"postmenopausal women","score":0.890999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8836712837219238},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6546599268913269},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6323014497756958},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5499663352966309},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5206815004348755},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5084754228591919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5079765915870667},{"id":"https://openalex.org/C185926286","wikidata":"https://www.wikidata.org/wiki/Q1929812","display_name":"Systemic therapy","level":4,"score":0.46404996514320374},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.45370668172836304},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4215373992919922},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33618462085723877},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.13288629055023193}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.vhri.2020.07.154","doi":"https://doi.org/10.1016/j.vhri.2020.07.154","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2020.07.154","pdf_url":null,"source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","medline","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.vhri.2020.07.154","doi":"https://doi.org/10.1016/j.vhri.2020.07.154","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.vhri.2020.07.154","pdf_url":null,"source":{"id":"https://openalex.org/S2764833115","display_name":"Value in Health Regional Issues","issn_l":"2212-1099","issn":["2212-1099","2212-1102"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","medline","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health Regional Issues","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4366608431","https://openalex.org/W4289519048","https://openalex.org/W2124979032","https://openalex.org/W4225644722","https://openalex.org/W3027327310","https://openalex.org/W3172815138","https://openalex.org/W2999038815","https://openalex.org/W2592453468","https://openalex.org/W3085934741","https://openalex.org/W6999449240"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2020-09-21T00:00:00"}